Victory Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.89M Sell
134,142
-18,504
-12% -$399K ﹤0.01% 1479
2025
Q1
$2.54M Sell
152,646
-9,479
-6% -$157K ﹤0.01% 1465
2024
Q4
$2.97M Buy
162,125
+64,995
+67% +$1.19M ﹤0.01% 1395
2024
Q3
$1.49M Buy
97,130
+2,708
+3% +$41.6K ﹤0.01% 1597
2024
Q2
$1.53M Buy
94,422
+14,700
+18% +$239K ﹤0.01% 1525
2024
Q1
$1.47M Sell
79,722
-18,631
-19% -$344K ﹤0.01% 1557
2023
Q4
$3.08M Sell
98,353
-1,212
-1% -$37.9K ﹤0.01% 1327
2023
Q3
$2.07M Buy
99,565
+21,394
+27% +$446K ﹤0.01% 1385
2023
Q2
$1.87M Sell
78,171
-409
-0.5% -$9.8K ﹤0.01% 1413
2023
Q1
$1.48M Buy
78,580
+5,032
+7% +$94.7K ﹤0.01% 1502
2022
Q4
$1.17M Buy
73,548
+55,539
+308% +$884K ﹤0.01% 1649
2022
Q3
$295K Sell
18,009
-360
-2% -$5.9K ﹤0.01% 2251
2022
Q2
$259K Buy
18,369
+180
+1% +$2.54K ﹤0.01% 2276
2022
Q1
$335K Sell
18,189
-286
-2% -$5.27K ﹤0.01% 2259
2021
Q4
$431K Sell
18,475
-561
-3% -$13.1K ﹤0.01% 2225
2021
Q3
$316K Sell
19,036
-2,166
-10% -$36K ﹤0.01% 2369
2021
Q2
$517K Sell
21,202
-1,672
-7% -$40.8K ﹤0.01% 2192
2021
Q1
$590K Buy
22,874
+1,302
+6% +$33.6K ﹤0.01% 2117
2020
Q4
$1.15M Sell
21,572
-1,862
-8% -$99.5K ﹤0.01% 1727
2020
Q3
$967K Buy
23,434
+731
+3% +$30.2K ﹤0.01% 1716
2020
Q2
$1.1M Sell
22,703
-22,713
-50% -$1.1M ﹤0.01% 1688
2020
Q1
$1.92M Buy
45,416
+22,728
+100% +$960K ﹤0.01% 1615
2019
Q4
$971K Buy
22,688
+3,479
+18% +$149K ﹤0.01% 1763
2019
Q3
$691K Buy
+19,209
New +$691K ﹤0.01% 1785
2018
Q3
Sell
-513
Closed -$8K 1784
2018
Q2
$8K Hold
513
﹤0.01% 1813
2018
Q1
$12K Hold
513
﹤0.01% 1805
2017
Q4
$15K Hold
513
﹤0.01% 1794
2017
Q3
$19K Hold
513
﹤0.01% 1776
2017
Q2
$14K Buy
513
+9
+2% +$246 ﹤0.01% 1786
2017
Q1
$17K Hold
504
﹤0.01% 1778
2016
Q4
$15K Buy
504
+28
+6% +$833 ﹤0.01% 1772
2016
Q3
$15K Buy
476
+33
+7% +$1.04K ﹤0.01% 1762
2016
Q2
$14K Buy
443
+9
+2% +$284 ﹤0.01% 1608
2016
Q1
$12K Buy
434
+32
+8% +$885 ﹤0.01% 1641
2015
Q4
$14K Buy
402
+23
+6% +$801 ﹤0.01% 1660
2015
Q3
$13K Buy
379
+31
+9% +$1.06K ﹤0.01% 1597
2015
Q2
$15K Buy
+348
New +$15K ﹤0.01% 1607